TREELINE
Live / Allowed — Notice of allowance issued (as of 11 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99068514
- Mark type
- Stylized text
- Filed
- 05 Mar 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Caitlin R. Byczko
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products, namely, preparations for the prevention and treatment of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders
- Class 042 — Scientific and technological services: pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; medical, pharmaceutical, and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders
Owner
- Treeline Biosciences, Inc., Watertown, MA, US
- Treeline Biosciences, Inc., Watertown, MA, US
Prosecution history
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2025 — ASSIGNED TO EXAMINER
- 05 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 05 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Mar 2025 — NEW APPLICATION ENTERED